DGKA and endometrial cancer: Using the Hec-1A endometrial cancer cell line it has been demonstrated that diacylglycerol kinase alpha (DGKA) activity is required for E2-stimulated cell proliferation, as using DGKA inhibitors resulted in E2-stimulated proliferation and growth of Hec-1A cells [85].